← All organizations
Highest phase reached
Phase 2
First clinical trial
Jun 5, 2024Last known activity
Jun 5, 2024
Timeline
2020s
- Jan 1, 2021
Latticon Antibody Therapeutics, Inc— Founded
Drugs by trial phase (1 distinct, 1 trials)
Phase 2 (1 own, 0 via acquisition)
Recent trials (2)
- NCT06277219Lead sponsorPhase 1/Phase 2Jun 5, 2024
- NCT06277219OfficialPhase 1/Phase 2Jun 5, 2024
Details
- Founded
- Gaithersburg, MD, US Jan 1, 2021
- Last known activity
- Jun 5, 2024